European Commission approves Malta’s R&D scheme

European Commission approves Malta’s R&D scheme

On 22 April, the European Commission approved a €5.3 million Maltese direct grants scheme to support R&D projects related to the COVID-19 outbreak.


On 22 April, the European Commission approved a €5.3 million Maltese direct grants scheme to support investment in research and development (R&D) related to the COVID-19 outbreak. The scheme was approved under the State aid Temporary Framework adopted by the Commission on 19 March 2020, as amended on 3 April 2020.

According to the Commission, the scheme will be accessible to Malta-based companies of all sizes, including public entities, carrying out coronavirus and other antiviral relevant R&D projects. The aim of the scheme is to support the development of innovative solutions to the current health crisis, such as relevant medicinal products and treatments, medical devices, hospital and medical equipment, disinfectants, data collection and processing tools, and applications supporting a better dissemination of recommendations by health authorities. Also, the scheme aims to improve foresight tools and methodologies for the future, by drawing on lessons learnt from the current pandemic.

The Commission found that the Maltese scheme is in line with the conditions set out in the Temporary Framework. In particular, the aid intensity varies between 80% and 100% of the costs incurred by the beneficiary, depending on the type of activity performed and on the presence of cross-border collaborations. Furthermore, under the scheme, any results of the research activities will be made available to third parties in the European Economic Area through non-exclusive licences.

Should you have any queries or wish to discuss further, please send an email to

European Commission approves Malta’s R&D scheme

The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavour to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation.

© 2024 KPMG, a Maltese civil partnership and a member firm of the KPMG global organisation of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved.

For more detail about the structure of the KPMG global organization please visit

Connect with us

Save, Curate and Share

Save what resonates, curate a library of information, and share content with your network of contacts.